首页> 美国卫生研究院文献>Acta Crystallographica Section F: Structural Biology and Crystallization Communications >Seeding for sirtuins: microseed matrix seeding to obtain crystals of human Sirt3 and Sirt2 suitable for soaking
【2h】

Seeding for sirtuins: microseed matrix seeding to obtain crystals of human Sirt3 and Sirt2 suitable for soaking

机译:sirtuins的播种:微种子基质播种以获得适合浸泡的人Sirt3和Sirt2晶体

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Sirtuins constitute a family of NAD+-dependent enzymes that catalyse the cleavage of various acyl groups from the ∊-amino group of lysines. They regulate a series of cellular processes and their misregulation has been implicated in various diseases, making sirtuins attractive drug targets. To date, only a few sirtuin modulators have been reported that are suitable for cellular research and their development has been hampered by a lack of structural information. In this work, microseed matrix seeding (MMS) was used to obtain crystals of human Sirt3 in its apo form and of human Sirt2 in complex with ADP ribose (ADPR). Crystal formation using MMS was predictable, less error-prone and yielded a higher number of crystals per drop than using conventional crystallization screening methods. The crystals were used to solve the crystal structures of apo Sirt3 and of Sirt2 in complex with ADPR at an improved resolution, as well as the crystal structures of Sirt2 in complex with ADPR and the indoles EX527 and CHIC35. These Sirt2–ADPR–indole complexes unexpectedly contain two indole molecules and provide novel insights into selective Sirt2 inhibition. The MMS approach for Sirt2 and Sirt3 may be used as the basis for structure-based optimization of Sirt2/3 inhibitors in the future.
机译:Sirtuins构成了NAD + 依赖型酶家族,可催化​​赖氨酸的γ-氨基裂解各种酰基。它们调节一系列细胞过程,并且其调节异常与多种疾病有关,从而使sirtuins成为有吸引力的药物靶标。迄今为止,仅报道了几种sirtuin调节剂,其适合细胞研究,并且其发展由于缺乏结构信息而受到阻碍。在这项工作中,微种子基质接种(MMS)用于获得载脂蛋白形式的人类Sirt3晶体以及与ADP核糖(ADPR)复合的人类Sirt2晶体。与传统的结晶筛选方法相比,使用MMS进行晶体形成是可预测的,不易出错,每滴产生的晶体数量更高。该晶体用于以改进的分辨率解析与ADPR复合的载脂蛋白Sirt3和Sirt2的晶体结构,以及与ADPR和吲哚EX527和CHIC35复合的Sirt2的晶体结构。这些Sirt2-ADPR-吲哚复合物意外地包含两个吲哚分子,为选择性抑制Sirt2提供了新颖的见解。 Sirt2和Sirt3的MMS方法可能会在将来用作Sirt2 / 3抑制剂基于结构优化的基础。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号